Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
ContributorsCorbacioglu, Selim; Cesaro, Simone; Faraci, Maura; Valteau-Couanet, Dominique; Gruhn, Bernd; Rovelli, Attilio; Boelens, Jaap J; Hewitt, Annette; Schrum, Johanna; Schulz, Ansgar S; Müller, Ingo; Stein, Jerry; Wynn, Robert; Greil, Johann; Sykora, Karl-Walter; Matthes-Martin, Susanne; Führer, Monika; O'Meara, Anne; Toporski, Jacek; Sedlacek, Petr; Schlegel, Paul G; Ehlert, Karoline; Fasth, Anders; Winiarski, Jacek; Arvidson, Johan; Mauz-Körholz, Christine; Ozsahin, Ayse Hulya; Schrauder, Andre; Bader, Peter; Massaro, Joseph; D'Agostino, Ralph; Hoyle, Margaret; Iacobelli, Massimo; Debatin, Klaus-Michael; Peters, Christina; Dini, Giorgio
Published inLancet, vol. 379, no. 9823, p. 1301-1309
Publication date2012
Abstract
Keywords
- Adolescent
- Bilirubin/blood
- Child
- Child, Preschool
- Female
- Fibrinolytic Agents/therapeutic use
- Graft vs Host Disease/epidemiology
- Hematopoietic Stem Cell Transplantation/adverse effects
- Hepatic Veno-Occlusive Disease/drug therapy/epidemiology/prevention & control
- Humans
- Incidence
- Infant
- Infusions, Intravenous
- Male
- Multiple Organ Failure/epidemiology
- Polydeoxyribonucleotides/therapeutic use
- Renal Insufficiency/epidemiology
Affiliation entities
Research groups
Citation (ISO format)
CORBACIOGLU, Selim et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. In: Lancet, 2012, vol. 379, n° 9823, p. 1301–1309. doi: 10.1016/S0140-6736(11)61938-7
Main files (1)
Article (Published version)
Identifiers
- PID : unige:31436
- DOI : 10.1016/S0140-6736(11)61938-7
- PMID : 22364685
Journal ISSN0140-6736
